FDA Application
-
Nystatin Oral Suspension USP
Company: UDL Laboratories, Inc.
Application No.: ANDA 64-142
Approval Date: 6/25/98
-
Approval Letter, Final Printed Labeling, and Chemistry Review(s) (PDF) (776 KB)
-
Bioequivalence Review(s) (PDF) (1.1 MB)
-
Correspondence (PDF) (1.9 MB)
Last update: June 30, 2005
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-